炎症性肠病不增加中轴型脊柱关节炎的疾病活动度或影像学进展风险
该纵向队列研究纳入1451例中轴型脊柱关节炎(axSpA)患者,其中184例(13%)合并炎症性肠病(IBD)。调整混杂因素后,IBD与活动性axSpA(OR 0.98,95%CI 0.75-1.28)及影像学进展(OR 1.45,95%CI 0.78-2.73)均无显著关联。
要点
- 合并IBD的axSpA患者HLA-B27阳性率更低,葡萄膜炎、外周关节炎和CRP升高比例更高。
- IBD与活动性axSpA风险无显著关联(OR 0.98,95%CI 0.75-1.28)。
- IBD与影像学进展风险无显著关联(OR 1.45,95%CI 0.78-2.73)。
核心结论
- 合并IBD的axSpA患者具有不同的临床特征,但疾病活动度和影像学进展并不比单纯axSpA患者更差。
- IBD与axSpA虽共享重叠的免疫发病机制,但IBD并不加剧axSpA的严重程度。
研究设计与样本
- 本研究为来自三级转诊中心的axSpA患者纵向队列研究。
- 活动性axSpA采用BASDAI≥4评估,数据集包含1268例患者。
- 影像学进展定义为2年内改良Stoke强直性脊柱炎评分(mSASSS)增加≥2个单位,在471例有纵向影像学数据的患者亚组中评估。
- 采用广义估计方程模型评估IBD与各结局的关联,并调整关键混杂因素。
主要发现
- 在1451例axSpA患者中,184例(13%)合并IBD。
- 与单纯axSpA患者相比,合并IBD者HLA-B27阳性率更低,葡萄膜炎、外周关节炎和C反应蛋白升高的比例更高。
- IBD与活动性axSpA风险增加无关(OR 0.98,95%CI 0.75-1.28)。
- IBD与影像学进展风险增加无关(OR 1.45,95%CI 0.78-2.73)。
- 考虑IBD状态随时间变化的敏感性分析证实了上述发现。
关键数值与推荐
- 活动性axSpA定义为BASDAI≥4。
- 影像学进展定义为2年内mSASSS增加≥2个单位。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需要进一步研究以探讨IBD严重程度和病程对axSpA长期结局的影响,从而阐明两种疾病之间的相互作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To examine whether inflammatory bowel disease (IBD) influences disease activity and radiographic progression in patients with axial spondyloarthritis (axSpA). METHODS: This was a longitudinal cohort study of axSpA patients from a tertiary referral centre. Active axSpA was assessed using the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI ≥4) in a dataset of 1268 patients. Radiographic progression, defined as a ≥ 2-unit increase in the modified Stoke Ankylosing Spondylitis Score (mSASSS) over 2 years, was evaluated in a subset of 471 patients with available longitudinal radiographic data. Generalized estimating equation models were used to assess associations between IBD and each outcome, adjusting for key confounders. RESULTS: Among 1451 axSpA patients, 184 (13%) had IBD. Compared with axSpA-only patients, those with IBD had lower HLA-B27 positivity and higher rates of uveitis, peripheral arthritis and elevated C-reactive protein. However, IBD was not associated with an increased risk of active axSpA (OR 0.98, 95% CI 0.75-1.28) or radiographic progression (OR 1.45, 95% CI 0.78-2.73). Sensitivity analyses accounting for time-varying IBD status confirmed these findings. CONCLUSION: AxSpA-IBD patients exhibited distinct clinical features but did not have worse disease activity or greater radiographic progression than those with axSpA alone. These findings suggest that while IBD and axSpA share overlapping immunopathogenic mechanisms, IBD does not exacerbate axSpA severity. Further research is needed to explore the effects of IBD severity and duration on long-term axSpA outcomes to delineate the interaction between these two diseases.
引用
- Remalante-Rayco P, Daghistani Y, Chim T, et al. Inflammatory bowel disease does not confer higher disease activity or greater radiographic progression in axial spondyloarthritis. Rheumatology (Oxford). 2025. PMID: 40824393. doi:10.1093/rheumatology/keaf420
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。